Table 1.
Participant’s characteristics at baseline.
|
HC |
SCD |
MCI |
AD |
p | |
|---|---|---|---|---|---|
| N = 31 | N = 29 | N = 23 | N = 22 | ||
| Females N (%) | 17 (55%) | 17 (59%) | 7 (30%) | 10 (46%) | 0.189a |
| Age [years] | 71 (8) | 69 (6) | 71 (6) | 75 (6) | 0.036b |
| Education [years] | 15 (3) | 16 (3) | 15 (3) | 14 (2) | 0.035b |
| APOE ε4 | |||||
| N carrier/non-carrier | 4/22 | 7/13 | 10/9 | 13/8 | 0.006a |
| (% carrier) | 15% | 35% | 53% | 62% |
Values are reported as mean (SD). Group differences for (a) categorical variables were tested with Chi2 test and (b) for continuous variables with ANOVA. APOE ε4 status was not available for all participants as indicated. Abbreviations: AD = Alzheimer’s disease, APOE ε4 = Apolipoprotein E ε4 allele, HC = Healthy control, MCI = Mild cognitive impairment, SCD = Subjective cognitive decline.